Xeriant, Inc.
XERI· OTC
XERIXeriant, Inc.
Filed May 14, 2024 · 10-Q · 44 days after period end · 0001477932-24-002829
| Metric | Q3 2024 | Q3 2023 | Q3 2022 | Q3 2021 |
|---|---|---|---|---|
| Net Income | -$376.33K | -$389.74K | -$2.80M | -$334.44K |
| EPS Diluted | $0.00 | — | — | $0.00 |
The same fiscal quarter, prior years. Thaler holds no estimates to compare against.
Xeriant, Inc. · CIK 1481504 · Engraved from SEC EDGAR
ended Mar 31, 2024 · filed May 14, 2024 · 44 d after period end
